MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/diagnostics15233032

Медицинская библиотека · Diagnostics (Basel, Switzerland) · 2025

Preoperative Breast MRI and Histopathology in Breast Cancer: Concordance, Challenges and Emerging Role of CEM and mpMRI.

Giannakaki Aikaterini-Gavriela, Giannakaki Maria-Nektaria, Baroutis Dimitris, Koura Sophia, Papachatzopoulou Eftychia, Marinopoulos Spyridon, Daskalakis Georgios, Dimitrakakis Constantine

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Background

Preoperative breast MRI is widely used in surgical planning because of its high sensitivity. However, discrepancies with histopathology remain common and can affect tumor size assessment and treatment decisions. In addition, recent comparative studies have highlighted the growing role of contrast-enhanced mammography (CEM) and multiparametric MRI (mpMRI), both of which may improve specificity and accessibility compared to conventional MRI.

Methods

A structured literature review was conducted in PubMed (2000-2025) according to PRISMA guidelines. Studies included if they evaluated preoperative breast MRI with histopathological correlation and reported sensitivity, specificity, or concordance outcomes. Data extraction focused on study design, patient and tumor characteristics, imaging methods, and clinical impact.

Results

MRI demonstrates high sensitivity, particularly in detecting IDC and ILC. However, overestimation of tumor size remains a concern, particularly in ILC and high-grade DCIS, while underestimation is frequently observed after neoadjuvant therapy, especially in Luminal A tumors. Tumor size and stage significantly affect concordance, with advanced-stage tumors (T2-T3) showing better MRI-histopathology concordance than early-stage lesions (T0-T1). Specificity remains limited, particularly in DCIS and multifocal disease. Emerging evidence suggests that contrast-enhanced mammography (CEM) achieves comparable sensitivity with higher specificity, while multiparametric MRI (mpMRI) incorporating diffusion-weighted imaging (DWI) improves lesion characterization and prediction of treatment response.

Conclusions

While MRI remains a valuable diagnostic tool for breast cancer, histopathological validation is essential to guide treatment decisions. Future research should focus on AI-enhanced imaging techniques, CEM and multiparametric MRI to improve concordance rates, reduce overdiagnosis and translate imaging advances into meaningful clinical outcomes.

Для цитирования: Giannakaki Aikaterini-Gavriela, Giannakaki Maria-Nektaria, Baroutis Dimitris, Koura Sophia, Papachatzopoulou Eftychia, Marinopoulos Spyridon, Daskalakis Georgios, Dimitrakakis Constantine. Preoperative Breast MRI and Histopathology in Breast Cancer: Concordance, Challenges and Emerging Role of CEM and mpMRI.. Diagnostics (Basel, Switzerland). 2025. DOI: 10.3390/diagnostics15233032.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.